Response to Wang et al's “Analysis of utilization, cost and, prescription trends of onychomycosis medications among Medicare patients”

Response to Wang et al's “Analysis of utilization, cost and, prescription trends of onychomycosis medications among Medicare patients^”

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	e277
Journal	Journal of the American Academy of Dermatology
Volume	88
Issue number	5
DOIs	https://doi.org/10.1016/j.jaad.2022.04.067
State	Published - May 2023
Externally published	Yes

@article{6dcc11c9e1704f6ea71c724e9ebcb4b4,

title = "Response to Wang et al's “Analysis of utilization, cost and, prescription trends of onychomycosis medications among Medicare patients”",

author = "Davis, {Michael J.} and Davis, {Loretta S.}",

year = "2023",

month = may,

doi = "10.1016/j.jaad.2022.04.067",

language = "English (US)",

volume = "88",

pages = "e277",

journal = "Journal of the American Academy of Dermatology",

issn = "0190-9622",

publisher = "Mosby Inc.",

number = "5",

}

TY - JOUR

T1 - Response to Wang et al's “Analysis of utilization, cost and, prescription trends of onychomycosis medications among Medicare patients”

AU - Davis, Michael J.

AU - Davis, Loretta S.

PY - 2023/5

Y1 - 2023/5

UR - http://www.scopus.com/inward/record.url?scp=85152627194&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85152627194&partnerID=8YFLogxK

U2 - 10.1016/j.jaad.2022.04.067

DO - 10.1016/j.jaad.2022.04.067

M3 - Letter

C2 - 35691490

AN - SCOPUS:85152627194

SN - 0190-9622

VL - 88

SP - e277

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

IS - 5

ER -